Skip to main content
SpringerLink
Log in

Chemotherapy, a double agent in respect of immune functions

  • Editorial
  • Chemotherapy and Immune Functions
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Al-Sarraf, M., Sardesai S., Vaitkevicius, V. K.: Clinical immunologic responsiveness in malignant disease. (2) In vitro response to phytohemagglutinin and the effect of cytotoxic drugs. Oncology 26, 357 (1972)

    CAS  PubMed  Google Scholar 

  • Bolton, P. A., Mander, A. M., Davidson, J. M., James, S. L., Necombre, R. G., Hughes, L. E.: Cellular immunity in cancer: comparison of delayed hypersensitivity skin tests in three common cancers. Brit. med. J. 1975 II, 18

  • Bonmassar, E., Testorelli, C., Franco, P., Goldin, A., Cudkowicz, G.: Changes of the immunogenic properties of a radiation-induced mouse lymphoma following treatment with antitumor drugs. Cancer Res. 35, 1957 (1975)

    Google Scholar 

  • Borella, L., Green, A. A., Webster, R. G.: Immunologic rebound after cessation of long-term chemotherapy in acute leukemia. Blood 40, 42 (1972)

    Google Scholar 

  • Campanile, F., Gaston, M., Bonmassar, E., Goldin, A.: Increased immunogenicity of two lymphomas following treatment with dimethyl trizeno-imidazole-carboxamide (TIC) in athymic-nude mice. Proc. Amer. Ass. Cancer. Res. 16, 36 (Abstract 142) (1975)

    Google Scholar 

  • Cardozo, E. L.: The effect of cytostatic therapy with cyclophosphamide alone or in combination with methotrexate on the PHA lymphocyte culture and on the immunoglobulins. Oncology 24, 261 (1970)

    Google Scholar 

  • Cheema, A. R., Hersh, E. M.: Patient'survival after chemotherapy and its relationship to in vitro lymphocyte blastogenesis. Cancer 28, 851 (1971)

    Google Scholar 

  • Clarysse, A., Kenis, Y., Mathé, G.: Cancer chemotherapy. Its role in the treatment strategy of hematologic malignancies and solid tumors. Berlin-Heidelberg-New York: Springer 1976

    Google Scholar 

  • Ezdinli, E., Simonson, K., Icli, F., Kerman, R.: Effects of single versus multiple agent therapy on cell-mediated immunity. Proc. Amer. Soc. Oncol. 18, 355 (Abstract C-353) (1977)

    Google Scholar 

  • Fidler, I. J.: Experimental basis for immunotherapy of metastatic disease. In: Immunotherapy of Human Cancer. 22nd Annual Clinical Conference, Houston (in press, 1978)

  • Fujimoto, S., Greene, M. I., Sehon, A. H.: Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumorbearing hosts. J. Immunol. 116, 791 (1976a)

    Google Scholar 

  • Fujimoto, S., Greene, M. I., Sehon, A. H.: Regulation of immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. J. Immunol. 116, 800 (1976b)

    Google Scholar 

  • Geffard, M., Orbach-Arbouys, S.: Enhancement of T suppressor activity in mice by high doses of BCG. Cancer Immunol. Immunother. 1, 41 (1976)

    Google Scholar 

  • Goldin, A., Houchens, D. P.: Chemotherapy modalities and immune condition of the host. In: Antibiotics Chemotherapy. Bâle: Karger (in press), (1978)

    Google Scholar 

  • Goodwin, J. S., Messner, R. P., Bankhurst, A. D., Peake, G. T., Saiki, J. H., Williams, R. C., Jr.: Prostaglandium-producing suppressor cells in Hodgkin's disease. New Engl. J. Med. 297, 963 (1977)

    CAS  PubMed  Google Scholar 

  • Gorczynski, R. M., Norbury, C.: Suppressor cells in murine sarcoma virus induced tumors. Cells in immunity. International Symposium, London, p. 149. Ontario: University of Western Ontario Press 1975

    Google Scholar 

  • Harris, J. K., Bagai, R. C., Stewart, T. H. M.: Serial monitoring of immune reactivity in cancer patients receiving chemotherapy as a means of predicting anti-tumor response. Proc. 7th Leucocyte Culture Congress. Daguillard, F. (ed.), p. 433. New York: Academic Press 1973

    Google Scholar 

  • Hersh, E. M.: Clinical rationale for immunotherapy and integration of immunotherapy into the strategy of cancer treatment. In: Immunotherapy of human cancer. 22nd Annual Clinical Conference, Houston, 1977 (in press, 1978)

  • Hersh, E. M., Oppenheim J. J.: Inhibition of in vitro lymphocyte transformation during chemotherapy in man. Cancer Res. 27, 98 (1967)

    Google Scholar 

  • Houchens, D. P., Bonmassar, E., Gaston, M., Goldin, A.: Drugmediated immunogenic changes of virus-induced leukemias in vivo. Cancer Res. 36, 1347 (1976)

    Google Scholar 

  • Imbach, J. L., Montero, J. L., Moruzzi, A., Serrou, B., Chenu, E., Hayat, M., Mathé, G.: The oncostatic and immunosuppressive action of new nitrosourea derivatives containing sugar radicals. Biomedicine 23, 410 (1975)

    Google Scholar 

  • Jones, K. D., Whitehead, R. H., Grimshaw, D., Hughes, L. E.: Lymphocyte response to chemotherapy in breast cancer (unpublished)

  • Joseph, R. R., Belpomme, D., Mathé, G.: Increase in “null” cells in acute lymphocytic leukaemia in remission on long-term immunotherapy. Brit. J. Cancer 33, 567 (1976)

    Google Scholar 

  • Kirchner, H., Chused, T. M., Herberman, R., et al.: Evidence of suppressor cell activity in spleen of mice bearing primary tumors induced by moloney sarcoma virus. J. exp. Med. 139, 1473 (1974)

    Google Scholar 

  • Lespinats, G., Poupon, M. F.: Données récentes sur l'immunologie des tumeurs. Mécanismes d'échappement au contrôle immunologique. Rôle des cellules suppressives. Bull. Cancer (Paris) 63, 269 (1976)

    Google Scholar 

  • Leventhal, B. G., Cohen, P., Triem, S. C.: Effect of chemotherapy on the immune response in acute leukemia. Israel J. med. Sci. 10, 866 (1974)

    Google Scholar 

  • Lubet, R. A., Carlson, D. E.: Tumor immunity directed against MOPC 104E: Effect of various therapeutic regimens. Cancer Immunol. Immunother. 2, 267 (1977)

    Google Scholar 

  • Maguire, H. C.: Increased tumor immunity with cyclophosphamide. Proc. Amer. Ass. Cancer Res. 18, 185 (Abstract 738) (1977)

    Google Scholar 

  • Mantovani, A.: In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages. Cancer Res. 37, 815 (1977)

    Google Scholar 

  • Mantovani, A., Tagliabue, A., Vecchi, A., Spreafico, F.: Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice. Europ. J. Cancer 12, 381 (1976)

    Google Scholar 

  • Mathé, G.: Cancer active immunotherapy. Immunoprophylaxis and immunogrestoration. An introduction. Berlin-Heidelberg-New York: Springer 1976

    Google Scholar 

  • Mathé, G.: Immune status and cancer chemotherapy. Cancer Immunol. Immunother. 2, 81 (1977a)

    Google Scholar 

  • Mathé, G.: Immunopharmacology and immunotherapy of residual disease in cancer patients. In: Medicinal Chemistry, Vol. V. Amsterdam: Elsevier 1977b

    Google Scholar 

  • Mathé, G., Schneider, M., Schwarzenberg, L.: The time factor in cancer chemotherapy. Europ. J. Cancer 6, 23 (1970)

    Google Scholar 

  • Mathé, G., Halle-Pannenko, O., Bourut, C.: Effectiveness of murine leukemia chemotherapy according to the immune status. Reconsideration of correlations between chemotherapy, tumor cell killing and survival time. Cancer Immunol. Immunother. 2, 139 (1977)

    Google Scholar 

  • McVie J. G., Logan, E. C. M., Kay, A. B.: Monocyte function in cancer patients. Europ. J. Cancer 13, 351 (1977)

    Google Scholar 

  • Mitsuoka, A., Baba, M., Morikawa, S.: Enhancement of delayed hypersensitivity by depletion of suppressor T-cells with cyclophosphamide in mice. Nature (Lond.) 262, 77 (1976)

    Google Scholar 

  • Nicolin A., Vadlamudi, S., Goldin, A.: Antigenicity of L1210 leukemic sublines induced by drugs. Cancer Res. 32, 653 (1972)

    Google Scholar 

  • Nicolin, A., Vadlamudi, S., Goldin, A.: Increased immunogenicity of murine lymphatic tumors by parazole-4-carboxamide, 3 (or 5)-amino (NSC-1402; PCA). Cancer Chemother. Rep. 57, 3 (1973)

    Google Scholar 

  • Nicolin, A., Bini, A., Franco, P., Goldin, A.: Cell-mediated response to mouse leukemic sublime antigenically altered following drug treatment in vivo. Cancer Chemother. Rep. 58, 325 (1974)

    Google Scholar 

  • Orbach-Arbouys, S., Poupon, M. F.: Active suppression of in vitro reactivity of spleen cells by BCG treatment. Immunology 13 (in press, 1978)

  • Orbach-Arbouys, S., Castes, M., Berardet, M.: Enhancement of immunological responses by methotrexate pretreatment as a result of an eventual elimination of suppressor cells. In: Experimental Hematology To-day. Heidelberg-Berlin-New York: Springer 1978

    Google Scholar 

  • Polak, L., Turk, J. L.: Reversal of immunological tolerance by cyclophosphamide through inhibition of suppressor cell activity. Nature (Lond.) 249, 654 (1974)

    Google Scholar 

  • Schneider, M.: Effets des chimiothérapies antimitotiques sur une réaction d'hypersensibilité retardée. Rev. franç. Étud. clin. biol. 13, 877 (1968)

    Google Scholar 

  • Schwartz, R., Dameshek, W.: Drug induced immunological tolerance. Nature (Lond.) 183, 1682 (1959)

    Google Scholar 

  • Simmler, M. C., Rameau, G., Chou, M. J. Mathé, G.: Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation. Israel J. med. Sci. 12, 472 (1976)

    Google Scholar 

  • Sy, M. S., Miller, S. D., Claman, H. N.: Immune suppression with supraoptional doses of antigen in contact sensitivity. I. Demonstration of suppressor cells and their sensitivity of cyclophosphamide. J. Immunol. 119, 240 (1977)

    Google Scholar 

  • Venditti, J. M., Goldin, A.: Drug synergism in antineoplastic chemotherapy. In: Advances in Chemotherapy, Vol. 1, p 397. New York: Academic Press 1964

    Google Scholar 

  • Weitzman, S. A., Aisenberg, A. C., Siber, G. R., Stossel, T. P., Smith, D. H.: The treatment of Hodgkin's disease (HD) and humoral immunity. Proc. Amer. Ass. Cancer Res. 18, 24 (Abstract 95) (1977)

    Google Scholar 

  • Winkelstein, A., Mikulla, J. M., Pollack, B. H., Stolzer, B. L.: Altered PHA responses in rheumatoid arthritis patients receiving cyclophosphamide. J. Lab. clin. Med. 80, 506 (1972)

    Google Scholar 

  • Wright, J. E., Soloway, A. H., Subramanyam, V., Gozzo, J. J.: Mustard haptens for chemoimmunotherapy of cancer. Proc. Amer. Ass. Cancer Res. 18, 233 (Abstract 932) (1977)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d'Hématologie de l'Institut Gustave-Roussy, Institut de Cancérologie et d'Immunogénétique, Hôpital Paul Brousse, F-94800, Villejuif, France

    G. Mathé

Authors
  1. G. Mathé
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mathé, G. Chemotherapy, a double agent in respect of immune functions. Cancer Chemother. Pharmacol. 1, 65–68 (1978). https://doi.org/10.1007/BF00254037

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00254037

Search

Navigation